Trading Ideas

Amazon.com Inc will protest the Pentagon’s decision to award a $10 billion cloud computing contract to Microsoft Corp, the Wall Street Journal reported (https://on.wsj.com/2CLjsdK) on Thursday, citing a statement. Amazon did not immediately respond to a Reuters request for comment. A challenge to the Defense Department’s award announced last month was widely expected by legal experts, analysts and consultants, especially after President Donald Trump publicly derided Amazon’s bid for the high-stakes contract. …read more […]

Nvidia beat Wall Street’s estimates for third-quarter revenue and earnings. Yahoo Finance’s Emily McCormick has the details. …read more […]

Netflix said on Thursday it would make changes to maps in a documentary that showed German Nazi death camps inside the borders of modern Poland, after Polish Prime Minister Mateusz Morawiecki pressed the streaming and production company to act. The maps in the documentary series “The Devil Next Door” were criticised by Morawiecki earlier this week for implying that Poland existed at that time as an independent nation within its postwar borders and thus could share responsibility for the atrocities committed at the camps during World War Two. …read more […]

Q3 2019 Infinera Corp Earnings Call …read more […]

When investors thought Canopy Growth (CGC) couldn’t report any worse numbers, the company shocked the market with another big miss. Digging into the numbers, the underlying trends were better than the headlines, but the leading Canadian cannabis LP has a long way to go before the business is supportive of the current valuation still around $5.2 billion.Big ChargesThe company officially reported FQ2 revenues of C$76.6 million. These revenues were hit by C$32.7 million in restructuring charges from returns and pricing allowances from the softgel and oil inventory and an inventory charge of C$15.9 million.These combined charges reduced gross margins by …read more […]

Boeing Co has scaled back use of automation to make fuselage sections for its 777 jetliners amid reports of reliability issues and returned to having mechanics do some of the work, the planemaker said on Thursday. The company began to build 777 fuselages in 2015 in an upright orientation, with robots drilling holes and installing fasteners, an initiative known as fuselage automated upright build (FAUB). Boeing had faced delays last year when the FAUB machine was tried out on existing versions of the 777. …read more […]

The video streaming wars went into overdrive this week. The Walt Disney Company (NYSE: DIS) launched its new service, Disney Plus, on November 12.
The conventional wisdom says Disney’s combination of price and quality content is bad news for Netflix (Nasdaq: NFLX).
However, I don’t believe this is a winner-take-all scenario. A recent Wall Street Journal and Harris Poll survey found Americans are willing to spend $44 per month on streaming services – meaning they can afford two or three different ones.
Still, Disney’s new service costs just $6.99 a month, which seems like a bargain compared with $12.99 for Netflix’s most popular …read more […]

A panel of experts to the U.S. FDA recommended allowing Amarin Corp Plc’s fish-oil derived drug to be used as an add-on therapy for reducing the chance of heart attacks and strokes in high-risk patients with cardiovascular disease. The panel on Thursday voted 16-0 in favor of expanding approval, potentially opening up a multi-billion dollar opportunity for the company which has only one drug, Vascepa, in the market. The FDA, which is slated to announce its final decision on the label expansion by Dec. 28, is not mandated to follow the recommendation of the panel, but generally does. …read more […]

House Speaker Pelosi tries to reassure Wall Street that impeachment won’t get in the way of ratifying USMCA. …read more […]

A panel of experts to the U.S. FDA on Thursday recommended allowing Amarin Corp Plc’s fish-oil derived drug to be used as add-on therapy for reducing the chance of heart attacks and strokes in high-risk patients with cardiovascular disease. The panel voted 16-0 in favor of expanding approval, potentially opening up a multi-billion dollar opportunity for the company which has only one drug, Vascepa, in the market. Vascepa, a highly purified omega-3 fatty acid derived from fish oil, won U.S. approval in 2012 to lower high levels of triglycerides — a type of blood fat that can increase …read more […]

The U.S. Food and Drug Administration on Thursday approved BeiGene Ltd’s lymphoma treatment, validating the China-based drugmaker’s strategy of largely using data from trials held outside the United States to file for approval. The company tested the treatment, Brukinsa, in 118 patients with mantle cell lymphoma enrolled in two studies. About three-quarters were Asian, 21% Caucasian, and between 10% to 15% were from the United States, BeiGene said. …read more […]

Firm of the great Ray Dalio buys Taiwan-focused ETF Continue reading… …read more […]

The U.S. budget deficit jumped 34% in October compared to last year, and it’s on pace to top $1 trillion. Federal reserve chair Jerome Powell testifying for the second day on the Hill, warning that the ballooning debt could hamper fiscal policy during economic downturn.. but he said the day of reckoning is still further out. Dan Deming, KKM Financial’s Managing Director joins Yahoo Finance’s Akiko Fujita on The Ticker. …read more […]

I love trading long-term equity anticipation securities (LEAPS)…
LEAPS are long-term options that have at least one year left before expiration. Since they are more expensive than short-term options (because of the extra time value), many people avoid them.
However, as a fundamental tactician, my goal is not always short-term gains…
Even though most of my trades, LEAPS included, are held for a very short time period.
Confused?
Let me explain…
Because LEAPS have a lot of time on them, a short-term move in underlying shares is magnified in a LEAPS option.
Think about it…
The options pricing model has several components, and a change in any one …read more […]

Cisco shares tumbled after the tech conglomerate provided disappointing guidance for it’s fiscal second-quarter. Yahoo Finance’s Dan Howley joins Akiko Fujita on The Ticker to discuss why the stock is down despite earnings beating Wall Street’s estimates. …read more […]